These disease-modifying effects of LanCL1 transgene might be a direct result of its role in protecting the MNs in the spinal cord from degeneration in the ALS model, as the age-dependent loss of spinal MNs is significantly delayed. The gene discussed is LANCL1; the disease is amyotrophic lateral sclerosis.